Comorbidity After Gastric Bypass
Launched by UPPSALA UNIVERSITY · Mar 11, 2016
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Comorbidity After Gastric Bypass," is looking at how Roux-en-Y gastric bypass (RYGB) surgery affects long-term health, particularly focusing on weight loss and related health conditions for people with severe obesity. The researchers want to understand how this surgery helps individuals not just to lose weight, but also to improve or manage other health issues that often come with obesity, such as diabetes or heart disease.
To be eligible for this study, participants need to be registered in the Scandinavian Obesity Surgery Registry and have already undergone gastric bypass surgery. The trial is open to all adults, regardless of gender. If you join the study, you can expect to share your health experiences over a five-year period, helping researchers gather valuable information that could benefit future patients. It’s important to note that this study is currently looking for participants, so if you fit the criteria, you could play a vital role in advancing our understanding of obesity treatment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Registered individuals in Scandinavian Obesity Surgery Registry (SOReg) having had gastric bypass
- Exclusion Criteria:
- • All other operations
About Uppsala University
Uppsala University, a prestigious institution located in Sweden, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive expertise in various fields of health sciences to conduct innovative studies aimed at improving patient outcomes and understanding complex diseases. With a strong emphasis on ethical standards and rigorous scientific methodologies, Uppsala University collaborates with a network of researchers, healthcare professionals, and industry partners to facilitate groundbreaking clinical trials that contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Uppsala, , Sweden
Patients applied
Trial Officials
Ingemar Näslund
Study Chair
Scandinavian Obesity Surgery Registry
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials